Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$260.71 USD

260.71
1,424,061

+2.88 (1.12%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $260.81 +0.10 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (159 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Universal Health (UHS) Receives Rating Action from Moody's

by Zacks Equity Research

Universal Health Services, Inc. (UHS) has recently received rating action from Moody's Investors Service, a wing of Moody's Corp. (MCO)

    Anthem Finally Walks Away from Cigna Merger, Seeks Charges

    by Zacks Equity Research

    Anthem Inc. (ANTM) has officially terminated its merger with Cigna.

      Worried About Volatility? Buy these 5 Low Leverage Stocks

      by Zacks Equity Research

      Considering the fact that sudden variability can hit the global market any time, it is better to choose stocks that bear relatively less risk. One of the investment strategies to choose less risky stocks is to measure a company's debt level.

        Aetna (AET) Calls it Quits on Unsustainable Public Exchanges

        by Zacks Equity Research

        In the wake of continued loss incurred by its public exchange business, health insurer Aetna Inc. (AET) has announced to pull back its presence.

          Top Ranked Momentum Stocks to Buy for May 10th

          by Zacks Equity Research

          Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 10th:

            Teladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact

            by Zacks Equity Research

            Teladoc Inc.'s (TDOC) operating loss of 30 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 33 cents per share.

              Cigna (CI) Beats on Q1 Earnings and Revenues, Guides Up

              by Zacks Equity Research

              Cigna (CI) earnings of $2.77 per share, comfortably beating the Zacks Consensus Estimate of $2.44.

                Molina Healthcare (MOH) Q4 Earnings, Revenues Beat Estimates

                by Zacks Equity Research

                Molina Healthcare Inc. (MOH) reported first-quarter 2017 adjusted net income per share of $1.47 that surpassed the Zacks Consensus Estimate of 57 cents by 157%.

                  Stock Market News for May 05, 2017

                  by Zacks Equity Research

                  Benchmarks mostly ended flat on Thursday amid drop in oil prices and the first steps taken by House Republicans to repeal Obamacare

                    Arpita Dutt headshot

                    Trumpcare Gets House Support: What Next?

                    by Arpita Dutt

                    Although the House of Representatives voted to repeal Obamacare, will the Senate vote for Trumpcare in its current form?

                      Company News for May 04, 2017

                      by Zacks Equity Research

                      Companies in the News are: YUM,CLX,RAI,HUM

                        Humana (HUM) Beats on Earnings, Misses Revenues in Q1

                        by Zacks Equity Research

                        Humana Inc.'s (HUM) first-quarter 2017 operating earnings per share of $2.75 beat the Zacks Consensus Estimate by approximately 8%.

                          Anupama Mukhopadhyay headshot

                          Humana's (HUM) Q1 Earnings Beat, Revenues Miss

                          by Anupama Mukhopadhyay

                          Humana (HUM) surpassed our earnings estimate. Our consensus called for EPS of $2.55, and the company reported EPS of $2.75.

                            Is a Surprise Coming for Humana (HUM) This Earnings Season?

                            by Zacks Equity Research

                            Humana (HUM) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.

                              Aetna (AET) Tops Q1 Earnings; Revenues Miss, Down Y/Y

                              by Zacks Equity Research

                              Aetna beats on earnings. Our consensus called for EPS of $2.36 and the company reported earnings per share of $2.71 and increased 17% year over year

                                Can CVS Health (CVS) Spring a Surprise this Earnings Season?

                                by Zacks Equity Research

                                CVS Health Corporation (CVS) is scheduled to report its first-quarter 2017 results before the opening bell on May 2.

                                  Universal Health (UHS) Q1 Earnings: What's in the Cards?

                                  by Zacks Equity Research

                                  Universal Health Services, Inc (UHS) is set to report first-quarter 2017 results on Apr 25, after the market closes.

                                    Will Boston Scientific (BSX) Surprise this Earnings Season?

                                    by Zacks Equity Research

                                    Boston Scientific Corporation (BSX) is scheduled to report first-quarter 2017 results before the opening bell on Apr 27.

                                      Will Thermo Fisher (TMO) Pull a Surprise in Q1 Earnings?

                                      by Zacks Equity Research

                                      Thermo Fisher Scientific, Inc. (TMO) is scheduled to report first-quarter 2017 results before the opening bell on Apr 26.

                                        What's in the Cards for Centene (CNC) this Earnings Season?

                                        by Zacks Equity Research

                                        Centene Corporation (CNC)will release first-quarter 2017 results on Apr 25, before the market opens.

                                          Will Zimmer Biomet (ZBH) Beat Earnings Estimates in Q1?

                                          by Zacks Equity Research

                                          Zimmer Biomet Holdings, Inc. (ZBH) is expected to beat earnings when it reports its first-quarter 2017 financial numbers on Apr 27.

                                            Aetna (AET) Hurt by Exchange Business, High Medical Costs

                                            by Zacks Equity Research

                                            Shares of health insurer Aetna Inc. (AET) underperformed over the past one year.

                                              Medicare Rates Rise More Than Expected, Insurers Breathe Easy

                                              by Zacks Equity Research

                                              The CMS has decided to raise 2018 Medicare Advantage more than expected.

                                                Why Is Humana (HUM) Up 5.2% Since the Last Earnings Report?

                                                by Zacks Equity Research

                                                Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                  Is Anthem (ANTM) About to Exit Public Exchange Business?

                                                  by Zacks Equity Research

                                                  Anthem Inc. (ANTM) is planning to scale back its participation on loss making public exchange business for 2018, as per analysts who met management.